Riddhi Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.98 M
About Riddhi Diagnostics
Riddhi Diagnostics Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 2020 (Four years and two months 29 days old ). Its registered office is in Bilaspur, Chattisgarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹0.98 M.
Alok Agrawal, Rajeshri Ghatwai, Setty Naidu, and One other member serve as directors at the Company.
Company Details
-
Location
Bilaspur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110CT2020PTC010865
-
Company No.
010865
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Nov 2020
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Riddhi Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Agrawal
|
Director | 04-Nov-2020 | Current |
|
Rajeshri Ghatwai
|
Director | 04-Nov-2020 | Current |
|
Setty Naidu
|
Director | 04-Nov-2020 | Current |
|
Murali Aryasomayajula
|
Additional Director | 02-Nov-2021 | Current |
Financial Performance of Riddhi Diagnostics.
Enhance accessibility to Riddhi Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riddhi Diagnostics?
Unlock access to Riddhi Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.98 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2022 | Others | ₹0.98 M | Open |
How Many Employees Work at Riddhi Diagnostics?
Riddhi Diagnostics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riddhi Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riddhi Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.